clinical benefit of monitoring cyclosporine C2 and C4 in long-term liver transplant recipients

By Barakat O.   Peaston R.   Rai R.   Talbot D.   Manas D.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1535-1537

Elsevier

Access to resources Recommend Favorite

C2 single-point sampling to evaluate cyclosporine exposure in long-term renal transplant recipients

By Citterio F.   Scata M.C.   Borzi M.T.   Pozzetto U.   Castagneto M.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3133-3136

Elsevier

Access to resources Recommend Favorite

Clinical use of c2 monitoring in long-term liver transplant recipients

By Sterneck M.   Zadeh K.M.   Groteluschen R.   Broring D.   Rogiers X.   Fischer L.  

Transplantation Proceedings, Vol. 34, Iss. 8, 2002-12 ,pp. : 3304-3306

Elsevier

Access to resources Recommend Favorite

Optimizing neoral therapeutic drug monitoring with cyclosporine trough (C 0 ) and C 2 concentrations in stable renal allograft recipients

By Einecke G.   Mai I.   Diekmann F.   Fritsche L.   Boehler T.   Neumayer H.-H.   Budde K.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3102-3103

Elsevier

Access to resources Recommend Favorite

Pharmacokinetic and pharmacodynamic correlations of cyclosporine therapy in stable renal transplant patients: evaluation of long-term target C 2

By Brunet M.   Campistol J.M.   Millan O.   Vidal E.   Esforzado N.   Rojo I.   Jimenez O.   Oppenheimer F.   Corbella J.   Martorell J.  

International Immunopharmacology, Vol. 3, Iss. 7, 2003-07 ,pp. : 987-999

Elsevier

Access to resources Recommend Favorite